Brief: Chemometec Raises 2026/27 Revenue, EBITDA Guidance
05/10/2026 09:49
BRIEF-Chemometec Raises 2026/27 Revenue, EBITDA Guidance Oct 5 (Reuters) - Chemometec A/S CHEMM.CO:
RAISES 2026/27 REVENUE GUIDANCE TO DKK 560-590 MILLION
NOW EXPECTS EBITDA IN DKK 330-345 MILLION RANGE, UP FROM DKK 300-315 MILLION PREVIOUSLY.
Source text: ID:nGNE2s7wPH
Further company coverage: CHEMM.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation